Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (311-320 of 525) with videos related to

Pageof 53
Sort By:
Journal of Virology|February 1, 2019
Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1Matthew Zirui Tay, Erika L Kunz, Aaron Deal, et al.
The Lancet. HIV|October 3, 2020
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R Baden, Daniel J Stieh, Michal Sarnecki, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Ebiomedicine|February 2, 2024
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trialMaurine D Miner, Allan deCamp, Nicole Grunenberg, et al.
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2016
CXCL13 is a plasma biomarker of germinal center activityColin Havenar-Daughton, Madelene Lindqvist, Antje Heit, et al.
The Journal of Clinical Investigation|June 24, 2021
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challengeRena D Astronomo, Maria P Lemos, Sandeep R Narpala, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized MiceKevin Wiehe, Nathan I Nicely, Bradley Lockwood, et al.
Pageof 53

Showing results (311-320 of 525) with videos related to

Sort By:
Pageof 53
Journal of Virology|February 1, 2019
Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1Matthew Zirui Tay, Erika L Kunz, Aaron Deal, et al.
The Lancet. HIV|October 3, 2020
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R Baden, Daniel J Stieh, Michal Sarnecki, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Ebiomedicine|February 2, 2024
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trialMaurine D Miner, Allan deCamp, Nicole Grunenberg, et al.
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2016
CXCL13 is a plasma biomarker of germinal center activityColin Havenar-Daughton, Madelene Lindqvist, Antje Heit, et al.
The Journal of Clinical Investigation|June 24, 2021
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challengeRena D Astronomo, Maria P Lemos, Sandeep R Narpala, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaquesJaimie D Sixsmith, Michael W Panas, Sunhee Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized MiceKevin Wiehe, Nathan I Nicely, Bradley Lockwood, et al.
Pageof 53